Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

Summary, in English

The aim was to investigate whole-body and red marrow absorbed doses in treatments of neuroblastoma (NB) and adult neuroendocrine tumors (NETs) with (131)I-metaiodobenzylguanidine and to propose a simple method for determining the activity to administer when dosimetric data for the individual patient are not available.

• Författare: PABLO MINGUEZ GABINA; Glenn Flux; Jose Genolla; Sonia Guayambuco; Alejandro Delgado; Jose Cruz Fombellida; Katarina Sjögreen Gleisner
• Avdelning/ar: Medicinsk strålningsfysik, Lund
• Publiceringsår: 2015
• Språk: Engelska
• Sidor: 3969-3978
• Publikation/Tidskrift/Serie: Medical Physics
• Volym: 42
• Issue: 7
• Fulltext: - 766 kB; Download statistics
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/26133597?dopt=Abstract; http://dx.doi.org/10.1118/1.4921807
• Dokumenttyp: Artikel i tidskrift
• Förlag: American Association of Physicists in Medicine
• Ämne: Radiology, Nuclear Medicine and Medical Imaging
• Aktiv: Published
• ISBN/ISSN/Övrigt: ISSN: 0094-2405